1. Home
  2. RVMD vs QRVO Comparison

RVMD vs QRVO Comparison

Compare RVMD & QRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • QRVO
  • Stock Information
  • Founded
  • RVMD 2014
  • QRVO 1957
  • Country
  • RVMD United States
  • QRVO United States
  • Employees
  • RVMD N/A
  • QRVO N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • QRVO Semiconductors
  • Sector
  • RVMD Health Care
  • QRVO Technology
  • Exchange
  • RVMD Nasdaq
  • QRVO Nasdaq
  • Market Cap
  • RVMD 7.5B
  • QRVO 7.9B
  • IPO Year
  • RVMD 2020
  • QRVO 1997
  • Fundamental
  • Price
  • RVMD $43.81
  • QRVO $87.67
  • Analyst Decision
  • RVMD Strong Buy
  • QRVO Hold
  • Analyst Count
  • RVMD 16
  • QRVO 19
  • Target Price
  • RVMD $73.56
  • QRVO $93.83
  • AVG Volume (30 Days)
  • RVMD 2.1M
  • QRVO 1.6M
  • Earning Date
  • RVMD 11-05-2025
  • QRVO 10-28-2025
  • Dividend Yield
  • RVMD N/A
  • QRVO N/A
  • EPS Growth
  • RVMD N/A
  • QRVO N/A
  • EPS
  • RVMD N/A
  • QRVO 0.85
  • Revenue
  • RVMD N/A
  • QRVO $3,651,078,000.00
  • Revenue This Year
  • RVMD N/A
  • QRVO $2.18
  • Revenue Next Year
  • RVMD $454.11
  • QRVO $4.34
  • P/E Ratio
  • RVMD N/A
  • QRVO $103.67
  • Revenue Growth
  • RVMD N/A
  • QRVO N/A
  • 52 Week Low
  • RVMD $29.17
  • QRVO $49.46
  • 52 Week High
  • RVMD $62.40
  • QRVO $107.33
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 63.22
  • QRVO 44.36
  • Support Level
  • RVMD $39.73
  • QRVO $85.69
  • Resistance Level
  • RVMD $47.21
  • QRVO $88.19
  • Average True Range (ATR)
  • RVMD 1.81
  • QRVO 2.52
  • MACD
  • RVMD 0.57
  • QRVO -0.70
  • Stochastic Oscillator
  • RVMD 64.77
  • QRVO 23.46

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About QRVO Qorvo Inc.

Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.

Share on Social Networks: